Accelerating clinical development of HIV vaccine strategies: methodological challenges and considerations in constructing an optimised multi-arm phase I/II trial design

被引:0
作者
Laura Richert
Adélaïde Doussau
Jean-Daniel Lelièvre
Vincent Arnold
Véronique Rieux
Amel Bouakane
Yves Lévy
Geneviève Chêne
Rodolphe Thiébaut
机构
[1] Centre INSERM U897-Epidemiologie-Biostatistique,Université Bordeaux, ISPED
[2] Centre INSERM U897-Epidemiologie-Biostatistique,INSERM, ISPED
[3] Vaccine Research Institute (VRI),Faculté de Médecine
[4] CHU de Bordeaux,undefined
[5] Pole de sante publique,undefined
[6] INRIA SISTM,undefined
[7] INSERM U955,undefined
[8] Université Paris Est Créteil,undefined
[9] Groupe Henri-Mondor Albert-Chenevier,undefined
[10] Immunologie clinique,undefined
[11] French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS),undefined
[12] Centre INSERM U897,undefined
[13] Université Bordeaux,undefined
来源
Trials | / 15卷
关键词
Clinical trial; Design; Phase I; Phase II; Randomisation; Frequentist; Bayes; Stopping rule; Safety; HIV vaccine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 668 条
[1]  
Abdool Karim Q(2010)Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women Science 329 1168-1174
[2]  
Abdool Karim SS(2011)Prevention of HIV-1 infection with early antiretroviral therapy N Engl J Med 365 493-505
[3]  
Frohlich JA(2007)Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial Lancet 369 657-666
[4]  
Grobler AC(2012)Antiretroviral prophylaxis for HIV prevention in heterosexual men and women N Engl J Med 367 399-410
[5]  
Baxter C(2009)Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand N Engl J Med 361 2209-2220
[6]  
Mansoor LE(2006)HIV/AIDS preventive vaccine ‘prime-boost’ phase III trial: foundations and initial lessons learned from Thailand AIDS 20 1471-1479
[7]  
Kharsany AB(2012)The road to an effective HIV vaccine N Engl J Med 366 1343-1344
[8]  
Sibeko S(2011)Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study Lancet Infect Dis 11 507-515
[9]  
Mlisana KP(2083–2092)Efficacy Trial of a DNA/rAd5 HIV-1 preventive vaccine N Engl J Med 2013 369-1302
[10]  
Omar Z(2012)The design and evaluation of HIV-1 vaccines AIDS 26 1293-560